Semaglutide has been making headlines recently as the answer to obesity management, as the diabetes drug has also been shown to have led to significant weight loss among those who are on it. But is this the silver bullet we’re looking for? And how does it work? Prof Emeritus Dr Chan Siew Pheng, Consultant Endocrinologist, weighs in on the question of who would benefit from semaglutide treatment, and who shouldn’t rush to get on it.

Image Credit: Shutterstock

Produced by: Lim Sue Ann

Presented by: Tee Shiao Eek

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  managing disease,  medical advances

Tags:  semaglutide,  liraglutide,  GLP-1 RA,  obesity,  diabetes,  non communicable diseases,